Hochschulschrift
Pharmacokinetic, Pharmacodynamic : modeling and simulation of biomarker response to venlafaxine and sunitinib administration
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
25 cm
- Extent
-
IV, 165 S.
- Language
-
Englisch
- Notes
-
Ill., graph. Darst.
Bonn, Univ., Diss., 2011 (Nicht für den Austausch)
- Classification
-
Medizin, Gesundheit
- Creator
-
Lindauer, Andreas
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 2:11 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Lindauer, Andreas
Other Objects (12)
Pharmacokinetic, Pharmacodynamic Modeling and Simulation of Biomarker Response to Venlafaxine and Sunitinib Administration
Development of a Combined Pharmacokinetic Model for Lacosamide and its Metabolite for Integrated Pharmacokinetic Modeling in Humans
Integration of pharmacokinetic and intracellular models of interferon administration and induced responses
Pharmacokinetic-pharmacodynamic modeling of antibacterial agents in tissues and body fluids
Population pharmacokinetic modeling to understand antineoplastic treatment
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development and Research: Methodology, Applications, and Limitations
Translational physiologically-based pharmacokinetic (PBPK) modeling and simulation to support drug development and pharmacotherapy
Physiologically based pharmacokinetic (PBPK) modeling for dynamical liver function tests and CYP phenotyping
Monitoring of propofol in breath; pharmacokinetic modeling and design of a control system
Effects of pharmacokinetic gene variation on therapeutic drug levels and antidepressant treatment response
Effect of drugs on the cardiac transport, metabolism and action of idarubicin : pharmacokinetic and pharmacodynamic modeling
Pharmacokinetic, Pharmacodynamic Modeling and Simulation of Biomarker Response to Venlafaxine and Sunitinib Administration
Development of a Combined Pharmacokinetic Model for Lacosamide and its Metabolite for Integrated Pharmacokinetic Modeling in Humans
Integration of pharmacokinetic and intracellular models of interferon administration and induced responses
Pharmacokinetic-pharmacodynamic modeling of antibacterial agents in tissues and body fluids
Population pharmacokinetic modeling to understand antineoplastic treatment
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development and Research: Methodology, Applications, and Limitations
Translational physiologically-based pharmacokinetic (PBPK) modeling and simulation to support drug development and pharmacotherapy
Physiologically based pharmacokinetic (PBPK) modeling for dynamical liver function tests and CYP phenotyping
Monitoring of propofol in breath; pharmacokinetic modeling and design of a control system
Effects of pharmacokinetic gene variation on therapeutic drug levels and antidepressant treatment response
Effect of drugs on the cardiac transport, metabolism and action of idarubicin : pharmacokinetic and pharmacodynamic modeling
Pharmacokinetic, Pharmacodynamic Modeling and Simulation of Biomarker Response to Venlafaxine and Sunitinib Administration
Development of a Combined Pharmacokinetic Model for Lacosamide and its Metabolite for Integrated Pharmacokinetic Modeling in Humans
Integration of pharmacokinetic and intracellular models of interferon administration and induced responses
Pharmacokinetic-pharmacodynamic modeling of antibacterial agents in tissues and body fluids
Population pharmacokinetic modeling to understand antineoplastic treatment
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development and Research: Methodology, Applications, and Limitations
Translational physiologically-based pharmacokinetic (PBPK) modeling and simulation to support drug development and pharmacotherapy
Physiologically based pharmacokinetic (PBPK) modeling for dynamical liver function tests and CYP phenotyping
Monitoring of propofol in breath; pharmacokinetic modeling and design of a control system
Effects of pharmacokinetic gene variation on therapeutic drug levels and antidepressant treatment response